FDA Considers Capping SPF Values At 50+ Despite Efficacy Data
This article was originally published in The Rose Sheet
FDA might cap sun-protection factors at 50 or 50+ so as not to mislead consumers about the clinical benefit of sunscreens with higher SPF values, according to a proposed rule.
You may also be interested in...
Advertising Standards Authority says Green People Co. misled consumers with claims SPF 30 formulas filter out only 1% less UVB rays than SPF 50, trying to draw a negligible difference between the formulas. The claims appeared in a direct mailer and on the brand’s website in July 2019.
SPF claims would be capped at SPF 60+ under FDA’s proposed rule, and companies would be required to label products using the lowest SPF measured in testing and maintain test records that would be accessible to FDA during inspections. The proposal also includes new broad-spectrum requirements, among a host of other changes.
CDER's enforcement policy guidance for OTC monograph sunscreens clarifies that spray sunscreens are included in the agency's enforcement discretion. But CDER closes the door on other dosage forms that it also identified in its 2011 ANPR for whether delivery formats other than lotions, creams or other traditional forms would be eligible for the monograph.